Theriva Biologics TOVX
NYSE TOVX
$0.23 +0.01 (+3.33%)
As of: Oct 2, 2026 · 2:04 PM EDT

Theriva Biologics (TOVX) Goodwill impairment charges (2024)

Updated

Theriva Biologics' Goodwill impairment charges came in at $6,000 for Q4 2024, down 99.6% from the prior quarter.

Analysis

Theriva Biologics (TOVX) Goodwill impairment charges (2024) Analysis & Trends

For FY2024, Theriva Biologics' Goodwill impairment charges was $5.6 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Theriva Biologics 10.56 Mn 10.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 6,000.00
Sep 30, 2024 1.50 Mn
Jun 30, 2024 4.10 Mn
API Access

Theriva Biologics Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=TOVX&period=max&api_key=YOUR_API_KEY